Nektar soars today on J.P. Morgan healthcare conference

Nektar soars today on J.P. Morgan healthcare conference

Anybody still think that conferences, especially biotech conferences, don’t move stock prices? Shares of Nektar Therapeutics (NKTR) are up 7.65% today to $61.79 as of noon New York time on the company’s appearance at this week’s J.P. Morgan biotech conference. The slides from the company’s presentation today are in circulation but CEO Howard Robin doesn’t actually present until 2 p.m. New York time today.

Don’t forget to harvest your tax losses by the end of the year

Don’t forget to harvest your tax losses by the end of the year

U.S. stocks have had a great year in 2017. The Standard & Poor’s 500 stock index is ahead 18.66% for 2017 as of the close today, December 23. The NASDAQ Composite, heavy on tech stocks and financials, is ahead 28.2%. But there’s a good likelihood that you’ve got a tax loss or two–not everything you own is up for the year, probably, and not everything you own is up since you bought it way back whenever–and in a year like this tax losses can be especially valuable.